MedPath

Development of diagnostic technology for graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation using a novel T cell function analysis

Not Applicable
Conditions
Hematologic Malignancies, Aplastic Anemia
Registration Number
JPRN-UMIN000039389
Lead Sponsor
The Institute of Medical Science, The University of Tokyo
Brief Summary

npublished

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who are found to be inappropriate for this trial as judged by the principal investigator or the sub-investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the stimulus-responsive T cell rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath